Adagrasib
- Part D specialty tier in 80% of formularies (2026Q3)
- KRAZATI
Therapy management checklist
Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.
Loading the therapy management checklist…
Storage and cold chain
Adagrasib: storage and handling
- Freezing
- Not addressed
- Room temperature
- at or below 25°C (77°F)
Label statement
Store tablets at room temperature, 20°C to 25°C (68°F to 77°F).
- Room temperature
- at or below 30°C (86°F)
Label statement
Temperature excursions between 15°C and 30°C (59°F to 86°F) are permitted [see USP Controlled Room Temperature] .
- Room temperature
- at or below 25°C (77°F)
Label statement
How should I store KRAZATI? o Store KRAZATI at room temperature between 68°F to 77°F (20°C to 25°C). o KRAZATI comes in a child-resistant container. o KRAZATI comes with a desiccant (drying agent) in the container to keep the medicine dry.
- Back into the refrigerator
- Not addressed
- Light
- Not addressed
- Shaking
- Not addressed
All storage statements on the label (4)
- Store tablets at room temperature, 20°C to 25°C (68°F to 77°F).
- Temperature excursions between 15°C and 30°C (59°F to 86°F) are permitted [see USP Controlled Room Temperature] .
- KRAZATI (adagrasib) tablets are packaged in high-density polyethylene, white opaque, square bottles with desiccant and polypropylene, white, child resistant closures with a tamper-proof heat induction seal.
- How should I store KRAZATI? o Store KRAZATI at room temperature between 68°F to 77°F (20°C to 25°C). o KRAZATI comes in a child-resistant container. o KRAZATI comes with a desiccant (drying agent) in the container to keep the medicine dry.
FDA label version 13, effective March 25, 2026. DailyMed
Dosing and titration calendar
Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.
Loading dosing schedules…
Medicare Part D coverage
5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan
Patient assistance
No manufacturer program page is listed for this drug yet.
Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.
For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.